EMEA (Europe, Middle East and Africa) Anti-Infective Drugs Market Report 2017

Market: Pharma & Healthcare

, 110 pages report, published by QYResearch

Report ThumbnailApril-2017
In this report, the EMEA Anti-Infective Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K MT), revenue (Million USD), market share and growth rate of Anti-Infective Drugs for these regions, from 2012 to 2022 (forecast)
Europe: Germany, France, UK, Russia, Italy and Benelux;
Middle East: Saudi Arabia, Israel, UAE and Iran;
Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Anti-Infective Drugs market competition by top manufacturers/players, with Anti-Infective Drugs sales volume (K MT), price (USD/MT), revenue (Million USD) and market share for each manufacturer/player; the top players including
GlaxoSmithKline
Merck
Pfizer
Novartis AG
Gilead Sciences
Abbott
Wyeth
Sanofi-Aventis
Bristol-Myers Squibb
Johnson
Roche Pharma AG
Nanosphere
NanoViricides
Novabay Pharmaceuticals
Obetech
Optimer Pharmaceuticals
Basilea Pharmaceutica AG
Daiichi Sankyo
MerLion Pharma
Theravance

On the basis of product, this report displays the sales volume (K MT), revenue (Million USD), product price (USD/MT), market share and growth rate of each type, primarily split into
Antibiotic Drugs
Antiviral Drugs
Antifungal Drugs
Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K MT), market share and growth rate of Anti-Infective Drugs for each application, including
Hospital
Clinic
Home
Other

If you have any special requirements, please let us know and we will offer you the report as you want.

  • List of Tables and Figures
  • Figure Product Picture of Anti-Infective Drugs
  • Figure EMEA Anti-Infective Drugs Sales Volume (K MT) by Type (2012-2022)
  • Figure EMEA Anti-Infective Drugs Sales Volume Market Share by Type (Product Category) in 2016
  • Figure Antibiotic Drugs Product Picture
  • Figure Antiviral Drugs Product Picture
  • Figure Antifungal Drugs Product Picture
  • Figure Other Product Picture
  • Figure EMEA Anti-Infective Drugs Sales Volume (K MT) by Application (2012-2022)
  • Figure EMEA Sales Market Share of Anti-Infective Drugs by Application in 2016
  • Figure Hospital Examples
  • Figure Clinic Examples
  • Figure Home Examples
  • Figure Other Examples
  • Figure EMEA Anti-Infective Drugs Market Size (Million USD) by Region (2012-2022)
  • Figure Europe Anti-Infective Drugs Revenue (Million USD) and Growth Rate (2012-2022)
  • Figure Europe Anti-Infective Drugs Revenue (Million USD) Status and Forecast by Countries
  • Figure Middle East Anti-Infective Drugs Revenue (Million USD) and Growth Rate (2012-2022)
  • Figure Middle East Anti-Infective Drugs Revenue (Million USD) Status and Forecast by Countries
  • Figure Africa Anti-Infective Drugs Revenue (Million USD) and Growth Rate (2012-2022)
  • Figure Africa Anti-Infective Drugs Revenue (Million USD) Status and Forecast by Countries
  • Figure EMEA Anti-Infective Drugs Sales Volume and Growth Rate (2012-2022)
  • Figure EMEA Anti-Infective Drugs Revenue (Million USD) and Growth Rate (2012-2022)
  • Figure EMEA Anti-Infective Drugs Market Major Players Product Sales Volume (K MT) (2012-2017)
  • Table EMEA Anti-Infective Drugs Sales Volume (K MT) of Major Players (2012-2017)
  • Table EMEA Anti-Infective Drugs Sales Share by Players (2012-2017)
  • Figure 2016 Anti-Infective Drugs Sales Share by Players
  • Figure 2017 Anti-Infective Drugs Sales Share by Players
  • Figure EMEA Anti-Infective Drugs Market Major Players Product Revenue (Million USD) (2012-2017)
  • Table EMEA Anti-Infective Drugs Revenue (Million USD) by Players (2012-2017)
  • Table EMEA Anti-Infective Drugs Revenue Share by Players (2012-2017)
  • Table 2016 EMEA Anti-Infective Drugs Revenue Share by Players
  • Table 2017 EMEA Anti-Infective Drugs Revenue Share by Players
  • Table EMEA Anti-Infective Drugs Sale Price (USD/MT) by Players (2012-2017)
  • Table EMEA Anti-Infective Drugs Sales (K MT) and Market Share by Type (2012-2017)
  • Table EMEA Anti-Infective Drugs Sales Share by Type (2012-2017)
  • Figure Sales Market Share of Anti-Infective Drugs by Type (2012-2017)
  • Figure EMEA Anti-Infective Drugs Sales Market Share by Type (2012-2017)
  • Table EMEA Anti-Infective Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
  • Table EMEA Anti-Infective Drugs Revenue Share by Type (2012-2017)
  • Figure Revenue Market Share of Anti-Infective Drugs by Type in 2016
  • Table EMEA Anti-Infective Drugs Sale Price (USD/MT) by Type (2012-2017)
  • Table EMEA Anti-Infective Drugs Sales (K MT) and Market Share by Application (2012-2017)
  • Table EMEA Anti-Infective Drugs Sales Share by Application (2012-2017)
  • Figure Sales Market Share of Anti-Infective Drugs by Application (2012-2017)
  • Figure EMEA Anti-Infective Drugs Sales Market Share by Application in 2016
  • Table EMEA Anti-Infective Drugs Sales (K MT) and Market Share by Region (2012-2017)
  • Table EMEA Anti-Infective Drugs Sales Share by Region (2012-2017)
  • Figure Sales Market Share of Anti-Infective Drugs by Region (2012-2017)
  • Figure EMEA Anti-Infective Drugs Sales Market Share in 2016
  • Table EMEA Anti-Infective Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
  • Table EMEA Anti-Infective Drugs Revenue Share by Region (2012-2017)
  • Figure Revenue Market Share of Anti-Infective Drugs by Region (2012-2017)
  • Figure EMEA Anti-Infective Drugs Revenue Market Share Regions in 2016
  • Table EMEA Anti-Infective Drugs Sales Price (USD/MT) by Region (2012-2017)
  • Figure Europe Anti-Infective Drugs Sales (K MT) and Growth Rate (2012-2017)
  • Figure Europe Anti-Infective Drugs Revenue and Growth Rate (2012-2017)
  • Table Europe Anti-Infective Drugs Sales (K MT) by Type (2012-2017)
  • Table Europe Anti-Infective Drugs Market Share by Type (2012-2017)
  • Figure Europe Anti-Infective Drugs Market Share by Type in 2016
  • Table Europe Anti-Infective Drugs Sales (K MT) by Application (2012-2017)
  • Table Europe Anti-Infective Drugs Market Share by Application (2012-2017)
  • Figure Europe Anti-Infective Drugs Market Share by Application in 2016
  • Table Europe Anti-Infective Drugs Sales (K MT) by Countries (2012-2017)
  • Table Europe Anti-Infective Drugs Sales Market Share by Countries (2012-2017)
  • Figure Europe Anti-Infective Drugs Sales Market Share by Countries (2012-2017)
  • Figure Europe Anti-Infective Drugs Sales Market Share by Countries in 2016
  • Table Europe Anti-Infective Drugs Revenue (Million USD) by Countries (2012-2017)
  • Table Europe Anti-Infective Drugs Revenue Market Share by Countries (2012-2017)
  • Figure Europe Anti-Infective Drugs Revenue Market Share by Countries (2012-2017)
  • Figure Europe Anti-Infective Drugs Revenue Market Share by Countries in 2016
  • Figure Germany Anti-Infective Drugs Sales (K MT) and Growth Rate (2012-2017)
  • Figure France Anti-Infective Drugs Sales (K MT) and Growth Rate (2012-2017)
  • Figure UK Anti-Infective Drugs Sales (K MT) and Growth Rate (2012-2017)
  • Figure Russia Anti-Infective Drugs Sales (K MT) and Growth Rate (2012-2017)
  • Figure Italy Anti-Infective Drugs Sales (K MT) and Growth Rate (2012-2017)
  • Figure Benelux Anti-Infective Drugs Sales (K MT) and Growth Rate (2012-2017)
  • Figure Middle East Anti-Infective Drugs Sales (K MT) and Growth Rate (2012-2017)
  • Figure Middle East Anti-Infective Drugs Revenue (Million USD) and Growth Rate (2012-2017)
  • Table Middle East Anti-Infective Drugs Sales (K MT) by Type (2012-2017)
  • Table Middle East Anti-Infective Drugs Market Share by Type (2012-2017)
  • Figure Middle East Anti-Infective Drugs Market Share by Type (2012-2017)
  • Table Middle East Anti-Infective Drugs Sales (K MT) by Applications (2012-2017)
  • Table Middle East Anti-Infective Drugs Market Share by Applications (2012-2017)
  • Figure Middle East Anti-Infective Drugs Sales Market Share by Application in 2016
  • Table Middle East Anti-Infective Drugs Sales Volume (K MT) by Countries (2012-2017)
  • Table Middle East Anti-Infective Drugs Sales Volume Market Share by Countries (2012-2017)
  • Figure Middle East Anti-Infective Drugs Sales Volume Market Share by Countries in 2016
  • Table Middle East Anti-Infective Drugs Revenue (Million USD) by Countries (2012-2017)
  • Table Middle East Anti-Infective Drugs Revenue Market Share by Countries (2012-2017)
  • Figure Middle East Anti-Infective Drugs Revenue Market Share by Countries (2012-2017)
  • Figure Middle East Anti-Infective Drugs Revenue Market Share by Countries in 2016
  • Figure Saudi Arabia Anti-Infective Drugs Sales (K MT) and Growth Rate (2012-2017)
  • Figure Israel Anti-Infective Drugs Sales (K MT) and Growth Rate (2012-2017)
  • Figure UAE Anti-Infective Drugs Sales (K MT) and Growth Rate (2012-2017)
  • Figure Iran Anti-Infective Drugs Sales (K MT) and Growth Rate (2012-2017)
  • Figure Africa Anti-Infective Drugs Sales (K MT) and Growth Rate (2012-2017)
  • Figure Africa Anti-Infective Drugs Revenue (Million USD) and Growth Rate (2012-2017)
  • Table Africa Anti-Infective Drugs Sales (K MT) by Type (2012-2017)
  • Table Africa Anti-Infective Drugs Sales Market Share by Type (2012-2017)
  • Figure Africa Anti-Infective Drugs Sales Market Share by Type (2012-2017)
  • Figure Africa Anti-Infective Drugs Sales Market Share by Type in 2016
  • Table Africa Anti-Infective Drugs Sales (K MT) by Application (2012-2017)
  • Table Africa Anti-Infective Drugs Sales Market Share by Application (2012-2017)
  • Figure Africa Anti-Infective Drugs Sales Market Share by Application (2012-2017)
  • Table Africa Anti-Infective Drugs Sales Volume (K MT) by Countries (2012-2017)
  • Table Africa Anti-Infective Drugs Sales Market Share by Countries (2012-2017)
  • Figure Africa Anti-Infective Drugs Sales Market Share by Countries (2012-2017)
  • Figure Africa Anti-Infective Drugs Sales Market Share by Countries in 2016
  • Table Africa Anti-Infective Drugs Revenue (Million USD) by Countries (2012-2017)
  • Table Africa Anti-Infective Drugs Revenue Market Share by Countries (2012-2017)
  • Figure Africa Anti-Infective Drugs Revenue Market Share by Countries (2012-2017)
  • Figure Africa Anti-Infective Drugs Revenue Market Share by Countries in 2016
  • Figure South Africa Anti-Infective Drugs Sales (K MT) and Growth Rate (2012-2017)
  • Figure Nigeria Anti-Infective Drugs Sales (K MT) and Growth Rate (2012-2017)
  • Figure Egypt Anti-Infective Drugs Sales (K MT) and Growth Rate (2012-2017)
  • Figure Algeria Anti-Infective Drugs Sales (K MT) and Growth Rate (2012-2017)
  • Table GlaxoSmithKline Anti-Infective Drugs Basic Information List
  • Table GlaxoSmithKline Anti-Infective Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
  • Figure GlaxoSmithKline Anti-Infective Drugs Sales (K MT) and Growth Rate (2012-2017)
  • Figure GlaxoSmithKline Anti-Infective Drugs Sales Market Share in EMEA (2012-2017)
  • Figure GlaxoSmithKline Anti-Infective Drugs Revenue Market Share in EMEA (2012-2017)
  • Table Merck Anti-Infective Drugs Basic Information List
  • Table Merck Anti-Infective Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
  • Figure Merck Anti-Infective Drugs Sales (K MT) and Growth Rate (2012-2017)
  • Figure Merck Anti-Infective Drugs Sales Market Share in EMEA (2012-2017)
  • Figure Merck Anti-Infective Drugs Revenue Market Share in EMEA (2012-2017)
  • Table Pfizer Anti-Infective Drugs Basic Information List
  • Table Pfizer Anti-Infective Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
  • Figure Pfizer Anti-Infective Drugs Sales (K MT) and Growth Rate (2012-2017)
  • Figure Pfizer Anti-Infective Drugs Sales Market Share in EMEA (2012-2017)
  • Figure Pfizer Anti-Infective Drugs Revenue Market Share in EMEA (2012-2017)
  • Table Novartis AG Anti-Infective Drugs Basic Information List
  • Table Novartis AG Anti-Infective Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
  • Figure Novartis AG Anti-Infective Drugs Sales (K MT) and Growth Rate (2012-2017)
  • Figure Novartis AG Anti-Infective Drugs Sales Market Share in EMEA (2012-2017)
  • Figure Novartis AG Anti-Infective Drugs Revenue Market Share in EMEA (2012-2017)
  • Table Gilead Sciences Anti-Infective Drugs Basic Information List
  • Table Gilead Sciences Anti-Infective Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
  • Figure Gilead Sciences Anti-Infective Drugs Sales (K MT) and Growth Rate (2012-2017)
  • Figure Gilead Sciences Anti-Infective Drugs Sales Market Share in EMEA (2012-2017)
  • Figure Gilead Sciences Anti-Infective Drugs Revenue Market Share in EMEA (2012-2017)
  • Table Abbott Anti-Infective Drugs Basic Information List
  • Table Abbott Anti-Infective Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
  • Figure Abbott Anti-Infective Drugs Sales (K MT) and Growth Rate (2012-2017)
  • Figure Abbott Anti-Infective Drugs Sales Market Share in EMEA (2012-2017)
  • Figure Abbott Anti-Infective Drugs Revenue Market Share in EMEA (2012-2017)
  • Table Wyeth Anti-Infective Drugs Basic Information List
  • Table Wyeth Anti-Infective Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
  • Figure Wyeth Anti-Infective Drugs Sales (K MT) and Growth Rate (2012-2017)
  • Figure Wyeth Anti-Infective Drugs Sales Market Share in EMEA (2012-2017)
  • Figure Wyeth Anti-Infective Drugs Revenue Market Share in EMEA (2012-2017)
  • Table Sanofi-Aventis Anti-Infective Drugs Basic Information List
  • Table Sanofi-Aventis Anti-Infective Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
  • Figure Sanofi-Aventis Anti-Infective Drugs Sales (K MT) and Growth Rate (2012-2017)
  • Figure Sanofi-Aventis Anti-Infective Drugs Sales Market Share in EMEA (2012-2017)
  • Figure Sanofi-Aventis Anti-Infective Drugs Revenue Market Share in EMEA (2012-2017)
  • Table Bristol-Myers Squibb Anti-Infective Drugs Basic Information List
  • Table Bristol-Myers Squibb Anti-Infective Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
  • Figure Bristol-Myers Squibb Anti-Infective Drugs Sales (K MT) and Growth Rate (2012-2017)
  • Figure Bristol-Myers Squibb Anti-Infective Drugs Sales Market Share in EMEA (2012-2017)
  • Figure Bristol-Myers Squibb Anti-Infective Drugs Revenue Market Share in EMEA (2012-2017)
  • Table Johnson Anti-Infective Drugs Basic Information List
  • Table Johnson Anti-Infective Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
  • Figure Johnson Anti-Infective Drugs Sales (K MT) and Growth Rate (2012-2017)
  • Figure Johnson Anti-Infective Drugs Sales Market Share in EMEA (2012-2017)
  • Figure Johnson Anti-Infective Drugs Revenue Market Share in EMEA (2012-2017)
  • Table Roche Pharma AG Anti-Infective Drugs Basic Information List
  • Table Nanosphere Anti-Infective Drugs Basic Information List
  • Table NanoViricides Anti-Infective Drugs Basic Information List
  • Table Novabay Pharmaceuticals Anti-Infective Drugs Basic Information List
  • Table Obetech Anti-Infective Drugs Basic Information List
  • Table Optimer Pharmaceuticals Anti-Infective Drugs Basic Information List
  • Table Basilea Pharmaceutica AG Anti-Infective Drugs Basic Information List
  • Table Daiichi Sankyo Anti-Infective Drugs Basic Information List
  • Table MerLion Pharma Anti-Infective Drugs Basic Information List
  • Table Theravance Anti-Infective Drugs Basic Information List
  • Table Production Base and Market Concentration Rate of Raw Material
  • Figure Price Trend of Key Raw Materials
  • Table Key Suppliers of Raw Materials
  • Figure Manufacturing Cost Structure of Anti-Infective Drugs
  • Figure Manufacturing Process Analysis of Anti-Infective Drugs
  • Figure Anti-Infective Drugs Industrial Chain Analysis
  • Table Raw Materials Sources of Anti-Infective Drugs Major Manufacturers in 2016
  • Table Major Buyers of Anti-Infective Drugs
  • Table Distributors/Traders List
  • Figure EMEA Anti-Infective Drugs Sales (K MT) and Growth Rate Forecast (2017-2022)
  • Figure EMEA Anti-Infective Drugs Revenue and Growth Rate Forecast (2017-2022)
  • Figure EMEA Anti-Infective Drugs Price (USD/MT) and Trend Forecast (2017-2022)
  • Table EMEA Anti-Infective Drugs Sales (K MT) Forecast by Region (2017-2022)
  • Figure EMEA Anti-Infective Drugs Sales Market Share Forecast by Region (2017-2022)
  • Table EMEA Anti-Infective Drugs Revenue (Million USD) Forecast by Region (2017-2022)
  • Figure EMEA Anti-Infective Drugs Revenue Market Share Forecast by Region (2017-2022)
  • Table Europe Anti-Infective Drugs Sales (K MT) Forecast by Countries (2017-2022)
  • Figure Europe Anti-Infective Drugs Sales Market Share Forecast by Countries (2017-2022)
  • Table Europe Anti-Infective Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
  • Figure Europe Anti-Infective Drugs Revenue Market Share Forecast by Countries (2017-2022)
  • Table Middle East Anti-Infective Drugs Sales (K MT) Forecast by Countries (2017-2022)
  • Figure Middle East Anti-Infective Drugs Sales Market Share Forecast by Countries (2017-2022)
  • Table Middle East Anti-Infective Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
  • Figure Middle East Anti-Infective Drugs Revenue Market Share Forecast by Countries (2017-2022)
  • Table Africa Anti-Infective Drugs Sales (K MT) Forecast by Countries (2017-2022)
  • Figure Africa Anti-Infective Drugs Sales Market Share Forecast by Countries (2017-2022)
  • Table Africa Anti-Infective Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
  • Figure Africa Anti-Infective Drugs Revenue Market Share Forecast by Countries (2017-2022)
  • Table EMEA Anti-Infective Drugs Sales (K MT) Forecast by Type (2017-2022)
  • Figure EMEA Anti-Infective Drugs Sales Market Share Forecast by Type (2017-2022)
  • Table EMEA Anti-Infective Drugs Sales (K MT) Forecast by Application (2017-2022)
  • Figure EMEA Anti-Infective Drugs Sales Market Share Forecast by Application (2017-2022)
  • Table Research Programs/Design for This Report
  • Figure Bottom-up and Top-down Approaches for This Report
  • Figure Data Triangulation
  • Table Key Data Information from Secondary Sources
  • Table Key Data Information from Primary Sources
  • Table of Contents
  • EMEA (Europe, Middle East and Africa) Anti-Infective Drugs Market Report 2017
  • 1 Anti-Infective Drugs Overview
  • 1.1 Product Overview and Scope of Anti-Infective Drugs
  • 1.2 Classification of Anti-Infective Drugs
  • 1.2.1 EMEA Anti-Infective Drugs Market Size (Sales) Comparison by Type (2012-2022)
  • 1.2.2 EMEA Anti-Infective Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
  • 1.2.3 Antibiotic Drugs
  • 1.2.4 Antiviral Drugs
  • 1.2.5 Antifungal Drugs
  • 1.2.6 Other
  • 1.3 EMEA Anti-Infective Drugs Market by Application/End Users
  • 1.3.1 EMEA Anti-Infective Drugs Sales (Volume) and Market Share Comparison by Application (2012-2022
  • 1.3.2 Hospital
  • 1.3.3 Clinic
  • 1.3.4 Home
  • 1.3.5 Other
  • 1.4 EMEA Anti-Infective Drugs Market by Region
  • 1.4.1 EMEA Anti-Infective Drugs Market Size (Value) Comparison by Region (2012-2022)
  • 1.4.2 Europe Status and Prospect (2012-2022)
  • 1.4.3 Middle East Status and Prospect (2012-2022)
  • 1.4.4 Africa Status and Prospect (2012-2022)
  • 1.5 EMEA Market Size (Value and Volume) of Anti-Infective Drugs (2012-2022)
  • 1.5.1 EMEA Anti-Infective Drugs Sales and Growth Rate (2012-2022)
  • 1.5.2 EMEA Anti-Infective Drugs Revenue and Growth Rate (2012-2022)
  • 2 EMEA Anti-Infective Drugs Competition by Manufacturers/Players/Suppliers, Region, Type and Application
  • 2.1 EMEA Anti-Infective Drugs Market Competition by Players/Manufacturers
  • 2.1.1 EMEA Anti-Infective Drugs Sales Volume and Market Share of Major Players (2012-2017)
  • 2.1.2 EMEA Anti-Infective Drugs Revenue and Share by Players (2012-2017)
  • 2.1.3 EMEA Anti-Infective Drugs Sale Price by Players (2012-2017)
  • 2.2 EMEA Anti-Infective Drugs (Volume and Value) by Type/Product Category
  • 2.2.1 EMEA Anti-Infective Drugs Sales and Market Share by Type (2012-2017)
  • 2.2.2 EMEA Anti-Infective Drugs Revenue and Market Share by Type (2012-2017)
  • 2.2.3 EMEA Anti-Infective Drugs Sale Price by Type (2012-2017)
  • 2.3 EMEA Anti-Infective Drugs (Volume) by Application
  • 2.4 EMEA Anti-Infective Drugs (Volume and Value) by Region
  • 2.4.1 EMEA Anti-Infective Drugs Sales and Market Share by Region (2012-2017)
  • 2.4.2 EMEA Anti-Infective Drugs Revenue and Market Share by Region (2012-2017)
  • 2.4.3 EMEA Anti-Infective Drugs Sales Price by Region (2012-2017)
  • 3 Europe Anti-Infective Drugs (Volume, Value and Sales Price), by Players, Countries, Type and Application
  • 3.1 Europe Anti-Infective Drugs Sales and Value (2012-2017)
  • 3.1.1 Europe Anti-Infective Drugs Sales Volume and Growth Rate (2012-2017)
  • 3.1.2 Europe Anti-Infective Drugs Revenue and Growth Rate (2012-2017)
  • 3.2 Europe Anti-Infective Drugs Sales and Market Share by Type
  • 3.3 Europe Anti-Infective Drugs Sales and Market Share by Application
  • 3.4 Europe Anti-Infective Drugs Sales Volume and Value (Revenue) by Countries
  • 3.4.1 Europe Anti-Infective Drugs Sales Volume by Countries (2012-2017)
  • 3.4.2 Europe Anti-Infective Drugs Revenue by Countries (2012-2017)
  • 3.4.3 Germany Anti-Infective Drugs Sales and Growth Rate (2012-2017)
  • 3.4.4 France Anti-Infective Drugs Sales and Growth Rate (2012-2017)
  • 3.4.5 UK Anti-Infective Drugs Sales and Growth Rate (2012-2017)
  • 3.4.6 Russia Anti-Infective Drugs Sales and Growth Rate (2012-2017)
  • 3.4.7 Italy Anti-Infective Drugs Sales and Growth Rate (2012-2017)
  • 3.4.8 Benelux Anti-Infective Drugs Sales and Growth Rate (2012-2017)
  • 4 Middle East Anti-Infective Drugs (Volume, Value and Sales Price), by Region, Type and Application
  • 4.1 Middle East Anti-Infective Drugs Sales and Value (2012-2017)
  • 4.1.1 Middle East Anti-Infective Drugs Sales Volume and Growth Rate (2012-2017)
  • 4.1.2 Middle East Anti-Infective Drugs Revenue and Growth Rate (2012-2017)
  • 4.2 Middle East Anti-Infective Drugs Sales and Market Share by Type
  • 4.3 Middle East Anti-Infective Drugs Sales and Market Share by Application
  • 4.4 Middle East Anti-Infective Drugs Sales Volume and Value (Revenue) by Countries
  • 4.4.1 Middle East Anti-Infective Drugs Sales Volume by Countries (2012-2017)
  • 4.4.2 Middle East Anti-Infective Drugs Revenue by Countries (2012-2017)
  • 4.4.3 Saudi Arabia Anti-Infective Drugs Sales and Growth Rate (2012-2017)
  • 4.4.4 Israel Anti-Infective Drugs Sales and Growth Rate (2012-2017)
  • 4.4.5 UAE Anti-Infective Drugs Sales and Growth Rate (2012-2017)
  • 4.4.6 Iran Anti-Infective Drugs Sales and Growth Rate (2012-2017)
  • 5 Africa Anti-Infective Drugs (Volume, Value and Sales Price) by Players, Countries, Type and Application
  • 5.1 Africa Anti-Infective Drugs Sales and Value (2012-2017)
  • 5.1.1 Africa Anti-Infective Drugs Sales Volume and Growth Rate (2012-2017)
  • 5.1.2 Africa Anti-Infective Drugs Revenue and Growth Rate (2012-2017)
  • 5.2 Africa Anti-Infective Drugs Sales and Market Share by Type
  • 5.3 Africa Anti-Infective Drugs Sales and Market Share by Application
  • 5.4 Africa Anti-Infective Drugs Sales Volume and Value (Revenue) by Countries
  • 5.4.1 Africa Anti-Infective Drugs Sales Volume by Countries (2012-2017)
  • 5.4.2 Africa Anti-Infective Drugs Revenue by Countries (2012-2017)
  • 5.4.3 South Africa Anti-Infective Drugs Sales and Growth Rate (2012-2017)
  • 5.4.4 Nigeria Anti-Infective Drugs Sales and Growth Rate (2012-2017)
  • 5.4.5 Egypt Anti-Infective Drugs Sales and Growth Rate (2012-2017)
  • 5.4.6 Algeria Anti-Infective Drugs Sales and Growth Rate (2012-2017)
  • 6 EMEA Anti-Infective Drugs Manufacturers/Players Profiles and Sales Data
  • 6.1 GlaxoSmithKline
  • 6.1.1 Company Basic Information, Manufacturing Base and Competitors
  • 6.1.2 Anti-Infective Drugs Product Type, Application and Specification
  • 6.1.2.1 Product A
  • 6.1.2.2 Product B
  • 6.1.3 GlaxoSmithKline Anti-Infective Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  • 6.1.4 Main Business/Business Overview
  • 6.2 Merck
  • 6.2.1 Company Basic Information, Manufacturing Base and Competitors
  • 6.2.2 Anti-Infective Drugs Product Type, Application and Specification
  • 6.2.2.1 Product A
  • 6.2.2.2 Product B
  • 6.2.3 Merck Anti-Infective Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  • 6.2.4 Main Business/Business Overview
  • 6.3 Pfizer
  • 6.3.1 Company Basic Information, Manufacturing Base and Competitors
  • 6.3.2 Anti-Infective Drugs Product Type, Application and Specification
  • 6.3.2.1 Product A
  • 6.3.2.2 Product B
  • 6.3.3 Pfizer Anti-Infective Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  • 6.3.4 Main Business/Business Overview
  • 6.4 Novartis AG
  • 6.4.1 Company Basic Information, Manufacturing Base and Competitors
  • 6.4.2 Anti-Infective Drugs Product Type, Application and Specification
  • 6.4.2.1 Product A
  • 6.4.2.2 Product B
  • 6.4.3 Novartis AG Anti-Infective Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  • 6.4.4 Main Business/Business Overview
  • 6.5 Gilead Sciences
  • 6.5.1 Company Basic Information, Manufacturing Base and Competitors
  • 6.5.2 Anti-Infective Drugs Product Type, Application and Specification
  • 6.5.2.1 Product A
  • 6.5.2.2 Product B
  • 6.5.3 Gilead Sciences Anti-Infective Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  • 6.5.4 Main Business/Business Overview
  • 6.6 Abbott
  • 6.6.1 Company Basic Information, Manufacturing Base and Competitors
  • 6.6.2 Anti-Infective Drugs Product Type, Application and Specification
  • 6.6.2.1 Product A
  • 6.6.2.2 Product B
  • 6.6.3 Abbott Anti-Infective Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  • 6.6.4 Main Business/Business Overview
  • 6.7 Wyeth
  • 6.7.1 Company Basic Information, Manufacturing Base and Competitors
  • 6.7.2 Anti-Infective Drugs Product Type, Application and Specification
  • 6.7.2.1 Product A
  • 6.7.2.2 Product B
  • 6.7.3 Wyeth Anti-Infective Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  • 6.7.4 Main Business/Business Overview
  • 6.8 Sanofi-Aventis
  • 6.8.1 Company Basic Information, Manufacturing Base and Competitors
  • 6.8.2 Anti-Infective Drugs Product Type, Application and Specification
  • 6.8.2.1 Product A
  • 6.8.2.2 Product B
  • 6.8.3 Sanofi-Aventis Anti-Infective Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  • 6.8.4 Main Business/Business Overview
  • 6.9 Bristol-Myers Squibb
  • 6.9.1 Company Basic Information, Manufacturing Base and Competitors
  • 6.9.2 Anti-Infective Drugs Product Type, Application and Specification
  • 6.9.2.1 Product A
  • 6.9.2.2 Product B
  • 6.9.3 Bristol-Myers Squibb Anti-Infective Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  • 6.9.4 Main Business/Business Overview
  • 6.10 Johnson
  • 6.10.1 Company Basic Information, Manufacturing Base and Competitors
  • 6.10.2 Anti-Infective Drugs Product Type, Application and Specification
  • 6.10.2.1 Product A
  • 6.10.2.2 Product B
  • 6.10.3 Johnson Anti-Infective Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  • 6.10.4 Main Business/Business Overview
  • 6.11 Roche Pharma AG
  • 6.12 Nanosphere
  • 6.13 NanoViricides
  • 6.14 Novabay Pharmaceuticals
  • 6.15 Obetech
  • 6.16 Optimer Pharmaceuticals
  • 6.17 Basilea Pharmaceutica AG
  • 6.18 Daiichi Sankyo
  • 6.19 MerLion Pharma
  • 6.20 Theravance
  • 7 Anti-Infective Drugs Manufacturing Cost Analysis
  • 7.1 Anti-Infective Drugs Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Price Trend of Key Raw Materials
  • 7.1.3 Key Suppliers of Raw Materials
  • 7.1.4 Market Concentration Rate of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.2.1 Raw Materials
  • 7.2.2 Labor Cost
  • 7.2.3 Manufacturing Expenses
  • 7.3 Manufacturing Process Analysis of Anti-Infective Drugs
  • 8 Industrial Chain, Sourcing Strategy and Downstream Buyers
  • 8.1 Anti-Infective Drugs Industrial Chain Analysis
  • 8.2 Upstream Raw Materials Sourcing
  • 8.3 Raw Materials Sources of Anti-Infective Drugs Major Manufacturers in 2016
  • 8.4 Downstream Buyers
  • 9 Marketing Strategy Analysis, Distributors/Traders
  • 9.1 Marketing Channel
  • 9.1.1 Direct Marketing
  • 9.1.2 Indirect Marketing
  • 9.1.3 Marketing Channel Development Trend
  • 9.2 Market Positioning
  • 9.2.1 Pricing Strategy
  • 9.2.2 Brand Strategy
  • 9.2.3 Target Client
  • 9.3 Distributors/Traders List
  • 10 Market Effect Factors Analysis
  • 10.1 Technology Progress/Risk
  • 10.1.1 Substitutes Threat
  • 10.1.2 Technology Progress in Related Industry
  • 10.2 Consumer Needs/Customer Preference Change
  • 10.3 Economic/Political Environmental Change
  • 11 EMEA Anti-Infective Drugs Market Forecast (2017-2022)
  • 11.1 EMEA Anti-Infective Drugs Sales, Revenue and Price Forecast (2017-2022)
  • 11.1.1 EMEA Anti-Infective Drugs Sales and Growth Rate Forecast (2017-2022)
  • 11.1.2 EMEA Anti-Infective Drugs Revenue and Growth Rate Forecast (2017-2022)
  • 11.1.3 EMEA Anti-Infective Drugs Price and Trend Forecast (2017-2022)
  • 11.2 EMEA Anti-Infective Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
  • 11.3 Europe Anti-Infective Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
  • 11.4 Middle Eastt Anti-Infective Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
  • 11.5 Africa Anti-Infective Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
  • 11.6 EMEA Anti-Infective Drugs Sales Forecast by Type (2017-2022)
  • 11.7 EMEA Anti-Infective Drugs Sales Forecast by Application (2017-2022)
  • 12 Research Findings and Conclusion
  • 13 Appendix
  • 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
  • 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
  • 13.3 Disclaimer

Please select a license type

Share

Related Products

QYResearchEMEA (Europe, Middle East and Africa) Anti-Infective Drugs Market Report 2017 Product ThumbnailEMEA (Europe, Middle East and Africa) Anti-Infective Drugs Market Report 2017 , Industry ReportProduct #: 760983
GlobalData
TeleResearch
Global Markets Direct
GBI Research
MarketsandMarkets
MicroMarketMonitor
PayPal Acceptance Mark
SSL Certificate
Copyright © 2017 Global Market Analyst. All Rights Reserved